Future Focus: San Antonio lands one of its largest Cancer Grants to Bring in New Talent

February 27, 2020

CPRIT officials said this is one of the largest amounts San Antonio institutions have collectively received from the institute in a single funding round since it was established by Texas voters in 2007. CPRIT CEO Wayne Roberts said it’s also further indication that the Alamo City “continues to expand its cancer research and prevention prowess.”


Manjeet Rao, PhD, Awarded NCI, R01 Grant to Test Efficacy of Novel Drug

February 25, 2020

Dr. Manjeet Rao, Greehey CCRI Deputy Director (interim), was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in cancers. Cancer cells use various mechanisms to manage their survival such as repairing DNA […]

Manjeet Rao, PhD in his lab


Greehey CCRI Faculty Awarded $1.2M CPRIT Grant to Support Osteosarcoma Research

February 24, 2020

Written by: Will Sansom An award of $1.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) went to Greehey CCRI Deputy Director and principal investigator Manjeet Rao, PhD, professor of cell systems and anatomy, for studies of an enzyme protein that helps osteosarcoma cells to survive and spread.  The team, which includes co-principal investigator Yogesh Gupta, […]

Rao & Gupta


Luiz O.F. Penalva, PhD, Co-corresponding Senior Author on NPJ Genomic Medicine publication.

February 22, 2020

“Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles” Abstract Therapy resistance and recurrence in high-grade gliomas are driven by their populations of glioma stem cells (GSCs). Thus, detailed molecular characterization of GSCs is needed to develop more effective therapies. We conducted a study to identify differences in the splicing […]

Prof. Luiz O.F. Penalva, PhD




Technology News Network: Team Develop Drugs To Fight Leukemia and Lymphoma

December 9, 2019

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. The journal Nature Medicine reported the findings Dec. 2. “This is a new class of drugs called PROTACs that target […]



EurekAlert: Leukemia, lymphoma squarely in sights of new class of drugs

December 6, 2019

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. The journal Nature Medicine reported the findings Dec. 2.


Cell Reports: Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design

November 5, 2019

Author links open overlay panelJo LynneRokita123  Komal S.Rathi23  Maria F.Cardenas4  Kristen A.Upton1  JoyJayaseelan4  Katherine L.Cross5  JacobPfeil6  Laura E.Egolf17  Gregory P.Way8  AlvinFarrel2  Nathan M.Kendsersky19  KhushbuPatel2  Krutika S.Gaonkar23  ApexaModi18  Esther R.Berko1  GonzaloLopez12  ZalmanVaksman2  ChelseaMayoh10  JonasNance11  KristynMcCoy11  MichelleHaber10  KathrynEvans10  HannahMcCalmont10  KaterinaBendak10  Julia W.Böhm10  Glenn M.Marshall1012  VanessaTyrrell13  KarthikKalletla23  Frank K.Braun14  LinQi1516  YunchenDu1516  HuiyuanZhang1516Holly B.Lindsay1516  SiboZhao1516JackShu1516  PatriciaBaxter1516  ChristopherMorton17  DiasKurmashev18  SiyuanZheng18 […]